Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.


Journal

NPJ vaccines
ISSN: 2059-0105
Titre abrégé: NPJ Vaccines
Pays: England
ID NLM: 101699863

Informations de publication

Date de publication:
04 Mar 2023
Historique:
received: 15 07 2022
accepted: 17 02 2023
entrez: 4 3 2023
pubmed: 5 3 2023
medline: 5 3 2023
Statut: epublish

Résumé

Despite the success of the widely used attenuated yellow fever (YF) vaccine, its global supply remains a substantial barrier to implementing vaccination campaigns in endemic regions and combating emerging epidemics. In A129 mice and rhesus macaques, we evaluated the immunogenicity and protective activity of messenger RNA (mRNA) vaccine candidates encapsulated in lipid nanoparticles, expressing the pre-membrane and envelope proteins or the non-structural protein 1 of YF virus. Vaccine constructs induced humoral and cell-mediated immune responses in mice, resulting in protection against lethal YF virus infection after passive administration of serum or splenocytes from vaccinated mice. Vaccination of macaques induced sustained high humoral and cellular immune responses for at least 5 months after the second dose. Our data demonstrate that these mRNA vaccine candidates can be considered an attractive addition to the licensed YF vaccine supply based on the induction of functional antibodies correlating with protection and T-cell responses; they could alleviate the limited supply of current YF vaccines, mitigating future YF epidemics.

Identifiants

pubmed: 36871059
doi: 10.1038/s41541-023-00629-7
pii: 10.1038/s41541-023-00629-7
pmc: PMC9984760
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31

Informations de copyright

© 2023. The Author(s).

Références

Vaccine. 2001 Jun 14;19(27):3700-9
pubmed: 11395204
PLoS Pathog. 2009 Oct;5(10):e1000614
pubmed: 19816561
Cell Rep. 2019 Feb 5;26(6):1598-1613.e8
pubmed: 30726741
Nat Commun. 2018 Nov 1;9(1):4560
pubmed: 30385750
NPJ Vaccines. 2018 Dec 13;3:56
pubmed: 30564463
Sci Rep. 2017 Nov 7;7(1):14769
pubmed: 29116169
Wkly Epidemiol Rec. 2013 Jul 5;88(27):269-83
pubmed: 23909008
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
PLoS Pathog. 2016 Jul 27;12(7):e1005786
pubmed: 27463517
J Exp Med. 1937 May 31;65(6):767-86
pubmed: 19870633
Vaccine. 2010 Aug 16;28(36):5891-9
pubmed: 20638759
Sci Immunol. 2021 Jun 22;6(60):
pubmed: 34158390
Vaccine. 2010 May 14;28(22):3827-40
pubmed: 20347059
Am J Trop Med Hyg. 2013 Sep;89(3):434-44
pubmed: 24006295
Wkly Epidemiol Rec. ;92(16):193-204
pubmed: 28429585
Lancet Infect Dis. 2019 Jul;19(7):750-758
pubmed: 31104909
J Virol. 2019 Dec 12;94(1):
pubmed: 31597773
Emerg Top Life Sci. 2020 Dec 11;4(4):399-410
pubmed: 33258924
Vet Immunol Immunopathol. 2017 Mar;185:20-33
pubmed: 28241999
Immunology. 2021 Oct;164(2):386-397
pubmed: 34056709
Vaccines (Basel). 2021 Jan 18;9(1):
pubmed: 33477534
Viruses. 2020 Oct 30;12(11):
pubmed: 33143114
Clin Vaccine Immunol. 2006 Aug;13(8):821-9
pubmed: 16893980
Cell Mol Immunol. 2017 Jan;14(1):22-35
pubmed: 27264686
Pharmaceuticals (Basel). 2021 Sep 01;14(9):
pubmed: 34577591
PLoS Negl Trop Dis. 2016 May 10;10(5):e0004695
pubmed: 27163257
Dtsch Med Wochenschr. 1974 Nov 22;99(47):2386-92
pubmed: 4426258
Virol Sin. 2019 Jun;34(3):235-239
pubmed: 31127472
Hum Vaccin Immunother. 2022 Dec 31;18(1):1895644
pubmed: 33974507
MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):647-50
pubmed: 26086636
mBio. 2021 Feb 9;12(1):
pubmed: 33563822
Elife. 2021 Mar 16;10:
pubmed: 33722340
Am J Trop Med Hyg. 2018 Feb;98(2):420-431
pubmed: 29231157
J Travel Med. 2020 Jul 14;27(4):
pubmed: 32299099
Parasit Vectors. 2019 Oct 2;12(1):463
pubmed: 31578140
Biomedica. 2002 Jun;22(2):178-210
pubmed: 12152484
J Immunol Methods. 2021 Jan;488:112900
pubmed: 33075363
J Virol. 1986 Dec;60(3):1153-5
pubmed: 3783816
Front Immunol. 2018 Aug 02;9:1756
pubmed: 30116244
N Engl J Med. 2011 Apr 7;364(14):1326-33
pubmed: 21470010
Expert Opin Drug Deliv. 2014 Jun;11(6):885-99
pubmed: 24665982
J Gen Virol. 2015 Jun;96(Pt 6):1328-1339
pubmed: 25646269
J Clin Microbiol. 2012 Dec;50(12):4054-60
pubmed: 23052311
Am J Trop Med Hyg. 2012 Feb;86(2):359-72
pubmed: 22302874
Virology. 1993 Jan;192(1):132-41
pubmed: 8517015
Lancet Infect Dis. 2020 Jun;20(6):e129-e137
pubmed: 32386609
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
J Virol. 2007 Sep;81(17):9551-5
pubmed: 17582005
Vaccine. 1994 May;12(6):542-50
pubmed: 8036829
JAMA. 2008 Aug 27;300(8):960-2
pubmed: 18728272

Auteurs

Lex G Medina-Magües (LG)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA. medinamagues@wisc.edu.

Janine Mühe (J)

Infectious Diseases Research Unit, CureVac SE, Friedrich-Miescher-Straße 15, 72076, Tübingen, Germany.

Edith Jasny (E)

Infectious Diseases Research Unit, CureVac SE, Friedrich-Miescher-Straße 15, 72076, Tübingen, Germany.

Emily S Medina-Magües (ES)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA.

Nicole Roth (N)

Infectious Diseases Research Unit, CureVac SE, Friedrich-Miescher-Straße 15, 72076, Tübingen, Germany.

Jaime Lopera-Madrid (J)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA.

Cristhian Salas-Quinchucua (C)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA.

Cole Knuese (C)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA.

Benjamin Petsch (B)

Infectious Diseases Research Unit, CureVac SE, Friedrich-Miescher-Straße 15, 72076, Tübingen, Germany.

Jorge E Osorio (JE)

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, 53706, USA. jorge.osorio@wisc.edu.

Classifications MeSH